DKTK Translational Advisory Board (TAB)

The DKTK TAB is a new panel of international experts that supports the evaluation of project proposals within the Joint Funding Program since 2025.

Members:

• I. Hartung (Merck Healthcare, Darmstadt)
• D. Heenen (Kickcancer, Brüssel)
• M. van der Heijden (Netherlands Cancer Institute, Amsterdam)
• B. Möckel (QIAGEN GmbH, Hilden)
• K. Pantel (Universitätsklinikum Hamburg-Eppendorf, Hamburg)
• R. Pfeiffer (National Cancer Institute NIH, Bethesda, MD)
• M. Röhrl (Beth Israel Deaconess Medical Center, Boston, MA)
• E. Sala (Università Cattolica del Sacro Cuore, Rome)
• R. Schulze (SMS Sachsen, Dresden)
• B. Singers Sørensen (Aarhus University Hospital, Aarhus)
• P. Staber (Medical University of Vienna, Vienna)
• J. Stingl (UKHD, Heidelberg)
• K. Tasken (Oslo University Hospital, Oslo)